Day One Biopharmaceuticals's market cap is currently $1.20B. The company's EPS TTM is $-1.013; its P/E ratio is ―; Day One Biopharmaceuticals is scheduled to report earnings on March 10, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -383.00K	$ -531.00K	$ -199.00K	$ -155.00K	$ 0.00
Operating Income	$ -206.06M	$ -146.91M	$ -72.74M	$ -13.78M	$ -14.90M
EBITDA	$ -206.06M	$ -141.65M	$ -72.56M	$ -43.66M	$ -2.00K
Net Income	$ -188.92M	$ -132.18M	$ -70.44M	$ -40.51M	$ -14.71M
Balance Sheet
Cash & Short-Term Investments	$ 366.35M	$ 342.27M	$ 284.31M	$ 43.73M	$ 27.33M
Total Assets	$ 376.05M	$ 349.06M	$ 289.82M	$ 45.66M	$ 27.34M
Total Debt	$ 408.00K	$ 813.00K	$ 220.00K	$ 402.00K	$ 0.00
Net Debt	$ -230.38M	$ -84.45M	$ -284.09M	$ -43.33M	$ -27.33M
Total Liabilities	$ 29.51M	$ 17.02M	$ 8.67M	$ 94.16M	$ 32.52M
Stockholders' Equity	$ 346.54M	$ -269.67M	$ -127.49M	$ -54.20M	$ -10.67M
Cash Flow
Free Cash Flow	$ -150.08M	$ -109.90M	$ -56.54M	$ -13.58M	$ -4.51M
Operating Cash Flow	$ -146.85M	$ -109.87M	$ -48.54M	$ -13.49M	$ -4.51M
Investing Cash Flow	$ 128.38M	$ -255.07M	$ -8.00M	$ -92.00K	$ 0.00
Financing Cash Flow	$ 164.00M	$ 165.90M	$ 297.12M	$ 29.98M	$ 30.91M

Currency in USD

Day One Biopharmaceuticals Earnings and Revenue History

Income Statement >

Day One Biopharmaceuticals Debt to Assets

Balance Sheet >

Day One Biopharmaceuticals Cash Flow

Cash Flow >

Day One Biopharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing